Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 11451-11500 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06883708
Feasibility & Preliminary Impacts of an Online Psychoeducational Program (iSupport-Malaysia) for Informal Dementia Caregivers
NARecruiting
70 participants
Started: Feb 5, 2025 · Completed: Dec 31, 2026
3 conditions4 sponsors4 locations
NCT06611293
HOspital Versus Primary Care Breath Test Environment (HOPE) Study
N/ARecruiting
80 participants
Started: Feb 5, 2025 · Completed: Oct 31, 2026
1 condition1 sponsor2 locations
NCT06777823
Rejection Sensitivity and Puberty in Mental Health Vulnerability to Social Media Experiences in Early Adolescent Girls
NARecruiting
250 participants
Started: Feb 5, 2025 · Completed: Jun 30, 2029
3 conditions3 sponsors1 location
NCT06816056
Manual Therapy in Hemophilic Arthropathy of the Ankle
NARecruiting
13 participants
Started: Feb 5, 2025 · Completed: Jul 25, 2025
1 condition1 sponsor1 location
NCT06981494
Dexmedetomidine Versus Dexmedetomidine and Ketamine (Ketodex) in Ear and Nose Surgeries
NARecruiting
84 participants
Started: Feb 5, 2025 · Completed: Dec 10, 2025
1 condition1 sponsor1 location
NCT06733220
Balance in the Strabismic Patient Undergoing Strabismus Surgery
N/ARecruiting
50 participants
Started: Feb 5, 2025 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT06891690
Use of TDCS Stimulation in Neurological and Gynaecological Conditions
NARecruiting
300 participants
Started: Feb 5, 2025 · Completed: Dec 31, 2025
7 conditions1 sponsor1 location
NCT05649514
Sleep Impairment in Subjects at Risk of Developing Alzheimer's Disease
NARecruiting
50 participants
Started: Feb 5, 2025 · Completed: Dec 1, 2027
3 conditions2 sponsors1 location
NCT06756659
Home-based Cardiac Rehabilitation With Spot-jogging
NARecruiting
40 participants
Started: Feb 5, 2025 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT06808971
Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Perioperative Treatment of Locally Advanced Resectable GC/GEJ
PHASE2Recruiting
61 participants
Started: Feb 5, 2025 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT06791408
Clinical Study on the Accuracy of Real-time AI-assisted Endocytoscopy in the Diagnosis of Colorectal Diminutive Polyps
N/ARecruiting
600 participants
Started: Feb 5, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06680817
A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)
N/ARecruiting
850 participants
Started: Feb 5, 2025 · Completed: Jun 15, 2028
2 conditions1 sponsor45 locations
NCT06477653
Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents
PHASE2Recruiting
30 participants
Started: Feb 5, 2025 · Completed: Mar 30, 2027
1 condition1 sponsor1 location
NCT06645847
Targeting Aging With a Ketone Ester for Function in Frailty
NARecruiting
180 participants
Started: Feb 5, 2025 · Completed: Apr 1, 2028
4 conditions4 sponsors3 locations
NCT07116135
Speech Understanding and Listening Effort Benefits of Hearing Instruments
NARecruiting
30 participants
Started: Feb 5, 2025 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06672185
ARC101 in Advanced Solid Tumors
PHASE1Recruiting
70 participants
Started: Feb 5, 2025 · Completed: Aug 1, 2028
1 condition1 sponsor10 locations
NCT06731998
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
NARecruiting
48 participants
Started: Feb 5, 2025 · Completed: Dec 31, 2026
11 conditions1 sponsor1 location
NCT06809842
Analgesic Efficacy of Blocking Nerve to Vastus Lateralis Muscle Versus Lateral Femoral Cutaneous Nerve After Knee Surgeries
NARecruiting
80 participants
Started: Feb 5, 2025 · Completed: Jul 30, 2025
4 conditions1 sponsor1 location
NCT07146074
Early Radiotherapy Versus Observation for High-risk Asymptomatic or Minimally Symptomatic Bone Metastases
NARecruiting
120 participants
Started: Feb 5, 2025 · Completed: Feb 28, 2029
4 conditions2 sponsors8 locations
NCT06812143
Optimizing Strength Training in Older Adults
NARecruiting
68 participants
Started: Feb 5, 2025 · Completed: Jan 25, 2027
1 condition2 sponsors1 location
NCT06689085
52 Week Study of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
PHASE3Recruiting
100 participants
Started: Feb 5, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor13 locations
NCT06728059
Safety and Feasibility of a Machine-Learning Bolus Priming Added to Existing Control Algorithm
NARecruiting
16 participants
Started: Feb 5, 2025 · Completed: Jul 31, 2025
1 condition3 sponsors1 location
NCT06772753
Investigation of Psychedelic Effects in Psychoactive Substances
PHASE1Recruiting
50 participants
Started: Feb 5, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06840951
Priming CBT with RTMS for OCD
PHASE1Recruiting
10 participants
Started: Feb 5, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06785532
Effect of RNS in Treatment-refractory Tourette's Syndrome
NARecruiting
10 participants
Started: Feb 5, 2025 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT06675604
LEOPARD Training and Validation Data Collection Study
N/ARecruiting
4,500 participants
Started: Feb 4, 2025 · Completed: Feb 4, 2029
4 conditions5 sponsors22 locations
NCT06788639
A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting
N/ARecruiting
300 participants
Started: Feb 4, 2025 · Completed: Jun 30, 2044
2 conditions1 sponsor1 location
NCT06788652
A Study of Patients With Relapsed/Refractory Mantle Cell Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting
N/ARecruiting
300 participants
Started: Feb 4, 2025 · Completed: Sep 30, 2044
1 condition1 sponsor1 location
NCT06634368
Pilot Study of Hospital GamePlan4Care
NARecruiting
50 participants
Started: Feb 4, 2025 · Completed: May 30, 2026
1 condition1 sponsor1 location
NCT06794268
A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting
N/ARecruiting
300 participants
Started: Feb 4, 2025 · Completed: Aug 31, 2044
1 condition1 sponsor1 location
NCT06741475
Feasibility Study of Caregiver-Assist Strategy Training
NARecruiting
30 participants
Started: Feb 4, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor3 locations
NCT07017621
Qualitative Study on the Experiences of Mothers 6 to 12 Months After Their Participation in the Mother-baby Groups of the HUGS Study
N/ARecruiting
16 participants
Started: Feb 4, 2025 · Completed: Feb 4, 2026
2 conditions1 sponsor3 locations
NCT06852807
18F-mFBG PET Imaging in the Evaluation of Neuroblastoma
N/ARecruiting
200 participants
Started: Feb 4, 2025 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT06758128
Genetic and Immunity in Heart Failure
N/ARecruiting
215 participants
Started: Feb 4, 2025 · Completed: Sep 30, 2026
1 condition1 sponsor2 locations
NCT06300528
Pemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas
PHASE2Recruiting
27 participants
Started: Feb 4, 2025 · Completed: Dec 31, 2030
1 condition2 sponsors1 location
NCT06800703
Opioid Use Disorder and Pain
N/ARecruiting
180 participants
Started: Feb 4, 2025 · Completed: Jan 31, 2028
2 conditions3 sponsors1 location
NCT06803784
Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders
N/ARecruiting
110 participants
Started: Feb 4, 2025 · Completed: Dec 31, 2026
4 conditions2 sponsors1 location
NCT06829875
Are We Providing Timely Access to Musculoskeletal Outpatient Therapy Services? an Exploratory Study
N/ARecruiting
135 participants
Started: Feb 4, 2025 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT05745285
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
NARecruiting
400 participants
Started: Feb 4, 2025 · Completed: Nov 1, 2026
5 conditions2 sponsors3 locations
NCT06550609
Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis with Inhaled Pentamidine Plus Oral Miltefosine
PHASE2Recruiting
30 participants
Started: Feb 4, 2025 · Completed: Feb 29, 2028
1 condition1 sponsor1 location
NCT06495593
Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple Sclerosis
PHASE4Recruiting
5 participants
Started: Feb 4, 2025 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06724380
Detection of Health Risk Situations in the Anesthesia Consultation.
N/ARecruiting
218 participants
Started: Feb 4, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06743425
A Pilot Study of a Remote ADHD Monitoring Program
NARecruiting
36 participants
Started: Feb 4, 2025 · Completed: Jul 1, 2026
2 conditions4 sponsors2 locations
NCT07119437
Low Impact Laparoscopy In Bariatric Surgery
NARecruiting
128 participants
Started: Feb 4, 2025 · Completed: Oct 4, 2026
1 condition1 sponsor1 location
NCT06810245
Study of PIPE-791 for Subjects with Chronic Osteoarthritis Pain or Chronic Low Back Pain
PHASE1Recruiting
40 participants
Started: Feb 4, 2025 · Completed: Feb 15, 2026
2 conditions1 sponsor5 locations
NCT06808542
Pelvic Floor Dysfunction Among Female Physiotherapy Students: A Cross-Sectional Study
N/ARecruiting
180 participants
Started: Feb 4, 2025 · Completed: Apr 25, 2025
1 condition1 sponsor1 location
NCT07205588
Assessment of Dental Pathologies Using Digital Tools
N/ARecruiting
350 participants
Started: Feb 4, 2025 · Completed: Dec 31, 2027
3 conditions1 sponsor22 locations
NCT06756932
BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
PHASE1Recruiting
120 participants
Started: Feb 4, 2025 · Completed: Jul 30, 2027
3 conditions1 sponsor16 locations
NCT06794996
Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities
PHASE2Recruiting
45 participants
Started: Feb 4, 2025 · Completed: Dec 30, 2026
1 condition1 sponsor34 locations
NCT06709014
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD
PHASE3Recruiting
760 participants
Started: Feb 4, 2025 · Completed: Jun 30, 2028
1 condition2 sponsors84 locations